Deutsche Bank’s Damora Therapeutics DMRA Stock Holding History

Deutsche Bank’s Portfolio DMRA Stock Details DMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.37M	Buy	+52,774	New	+$1.28M	﹤0.01%	2135

Other funds holding DMRA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Remedium Capital Partners Fort Lauderdale, Florida $452M AUM

Deutsche Bank's DMRA Position: Q2 2026 in Review

Deutsche Bank opened a new position in Damora Therapeutics (DMRA) in Q2 2026: 52,774 shares worth $1.37M. The stake represents ﹤0.01% of the portfolio and ranks #2135 among its holdings.

104 funds tracked by Wall St. Rank hold DMRA as of Q2 2026.

Deutsche Bank held 52,774 shares of Damora Therapeutics worth $1.37M as of Q2 2026.
Damora Therapeutics was a new Deutsche Bank position in Q2 2026.
Damora Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2135 holding.
104 funds tracked by Wall St. Rank held Damora Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.